Canada markets open in 2 hours 21 minutes

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.9400+0.1600 (+5.76%)
At close: 04:00PM EDT
2.9000 -0.04 (-1.36%)
After hours: 04:53PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
21,696
23,683
19,834
22,984
22,328
Selling General and Administrative
9,827
10,240
10,073
9,492
10,161
Total Operating Expenses
31,523
33,923
29,907
32,476
32,489
Operating Income or Loss
-31,523
-33,923
-29,907
-32,476
-32,489
Interest Expense
1,244
391
1,163
1,202
456
Total Other Income/Expenses Net
-94
469
142
-293
-9
Income Before Tax
-32,189
-29,097
-29,188
-33,961
-32,776
Income Tax Expense
-22
-32
-36
-21
-18
Income from Continuing Operations
-32,167
-29,065
-29,152
-33,940
-32,758
Net Income
-32,167
-29,065
-29,152
-33,940
-32,758
Net Income available to common shareholders
-32,167
-29,065
-29,152
-33,940
-32,758
Basic EPS
-0.22
-
-0.45
-1.49
-1.81
Diluted EPS
-0.22
-
-0.45
-1.49
-1.81
Basic Average Shares
98,786
-
64,542
22,841
18,059
Diluted Average Shares
98,786
-
64,542
22,841
18,059